financetom
Business
financetom
/
Business
/
SK Innovation's Q2 losses deepen as refining margins suffer
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
SK Innovation's Q2 losses deepen as refining margins suffer
Jul 30, 2025 5:44 PM

SEOUL, July 31 (Reuters) - SK Innovation Co Ltd's

losses deepened in the second quarter due to

worsening profitability in its oil refining business.

The company, owner of South Korea's top refiner SK Energy,

posted an operating loss of 418 billion won ($301.20 million)

for the April-June period on Thursday, versus a 45.8 billion won

loss a year earlier.

The results were worse than an average analyst forecast for

a 140 billion won loss compiled by LSEG SmartEstimate.

($1 = 1,387.8000 won)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
NextDecade, EQT Ink 20-Year LNG Supply Agreement for Rio Grande Train 5
NextDecade, EQT Ink 20-Year LNG Supply Agreement for Rio Grande Train 5
Sep 3, 2025
05:46 PM EDT, 09/03/2025 (MT Newswires) -- NextDecade ( NEXT ) said late Wednesday that it has entered a 20-year deal to deliver 1.5 million tonnes per annum of liquefied natural gas to EQT (EQT) from its planned Rio Grande LNG Train 5 facility in Texas. The agreement increases Train 5's secured capacity to 3.5 MTPA, with NextDecade ( NEXT...
Pennant Acquires Home Health in Wyoming
Pennant Acquires Home Health in Wyoming
Sep 3, 2025
06:03 PM EDT, 09/03/2025 (MT Newswires) -- Pennant Group ( PNTG ) said late Wednesday it acquired home health agency and outpatient therapy operation in Wyoming. The businesses, which will continue operating as Healing Hearts Home Health and Healing Hearts Outpatient Therapy, will serve communities in Gillette and Moorcroft. Financial terms of the deal were not disclosed. ...
Senseonics Signs MoU to Assume Commercialization, Distribution of Eversense 365
Senseonics Signs MoU to Assume Commercialization, Distribution of Eversense 365
Sep 3, 2025
06:08 PM EDT, 09/03/2025 (MT Newswires) -- Senseonics Holdings ( SENS ) said late Wednesday it has entered into a memorandum of understanding with Ascensia Diabetes Care to assume commercialization and distribution of Eversense 365 continuous glucose monitoring system. Senseonics ( SENS ) said it would assume responsibility in the US from Jan. 1, 2026, and utilize Transition Service Agreements...
Avadel Pharmaceuticals Gets Exclusive License From XWPharma for Sleep Disorder Treatment
Avadel Pharmaceuticals Gets Exclusive License From XWPharma for Sleep Disorder Treatment
Sep 3, 2025
05:49 PM EDT, 09/03/2025 (MT Newswires) -- Avadel Pharmaceuticals ( AVDL ) secured an exclusive license to develop and commercialize XWPharma's sleep disorder treatment, valiloxybate, including a $20 million upfront payment. Avadel gains the global rights, excluding mainland China, Hong Kong and Macau, and XWPharma is eligible for development and regulatory milestone payments of up to $30 million, the companies...
Copyright 2023-2026 - www.financetom.com All Rights Reserved